Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Dri Healthcare Trust (DHT-UN.TO)

Dri Healthcare Trust (DHT-UN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dri Healthcare Trust 100 King Street West 1 First Canadian Place, Suite 7250 Toronto ON M5X 1B1 CAN

https://www.dricapital.com P: 416-863-1865 F: 416-863-5161

Description:

DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, primarily focused on acquiring royalty assets. Geographically the trust generates major revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.

Key Statistics

Overview:

Market Capitalization, $K 650,228
Shares Outstanding, K 56,358
Annual Sales, $ 217,981 K
Annual Net Income, $ 92,304 K
Last Quarter Sales, $ 25,054 K
Last Quarter Net Income, $ -6,197 K
60-Month Beta 1.06
% of Institutional Shareholders 2.22%

Growth:

1-Year Return 8.75%
3-Year Return 30.24%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date 08/06/24
Earnings Per Share ttm 1.99
EPS Growth vs. Prev Year 5.90%
Annual Dividend Rate, $ 0.31
Annual Dividend Yield 4.00%
Most Recent Dividend 0.085 on 03/27/24
Next Ex-Dividends Date 06/28/24
Dividend Payable Date 07/19/24
Dividend Payout Ratio 15.58%

DHT-UN.TO Ratios

Ratio
Price/Earnings ttm 4.30
Price/Earnings forward 212.77
Price/Earnings to Growth N/A
Return-on-Equity % 18.96%
Return-on-Assets % 10.93%
Profit Margin % 42.35%
Debt/Equity 0.26
Price/Sales 1.93
Price/Book 0.87
Book Value/Share 13.38

DHT-UN.TO Dividends

Date Value
06/28/24 $0.0850
03/27/24 $0.0850
12/28/23 $0.2662
09/28/23 $0.0750
06/29/23 $0.5334
03/30/23 $0.0750
12/29/22 $0.0750
09/28/22 $0.0750
06/29/22 $0.0750
03/30/22 $0.0750
12/30/21 $0.2200
09/28/21 $0.0375
06/29/21 $0.0375
03/30/21 $0.0167
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar